Neuraxis, Inc.

NRXSAMEXUSD
7.51 USD
0.26 (3.61%)🟢LIVE (AS OF 02:49 PM EDT)
🟢Market: OPEN
Open?$7.35
High?$7.64
Low?$7.00
Prev. Close?$7.25
Volume?148.7K
Avg. Volume?202.1K
VWAP?$7.33
Rel. Volume?0.74x
Bid / Ask
Bid?$7.42 × 100
Ask?$7.55 × 100
Spread?$0.13
Midpoint?$7.48
Valuation & Ratios
Market Cap?81.1M
Shares Out?11.2M
Float?4.9M
Float %?45.9%
P/E Ratio?N/A
P/B Ratio?23.86
EPS?-$0.77
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.05Strong
Quick Ratio?1.96Adequate
Cash Ratio?1.78Strong
Debt/Equity?0.04Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
23.86HIGH
P/S?
22.72HIGH
P/FCF?
N/A
EV/EBITDA?
-9.8CHEAP
EV/Sales?
21.38HIGH
Returns & Efficiency
ROE?
-253.4%WEAK
ROA?
-134.5%WEAK
Cash Flow & Enterprise
FCF?$-6463993
Enterprise Value?$76.3M
Related Companies
Loading...
News
Profile
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Employees
24
Market Cap
81.1M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2023-08-09
Address
11611 N. MERIDIAN ST
CARMEL, IN 46032
Phone: (812) 689-0791